WantenG.J.A., van OostP., SchneebergerP.M., KoolenM.Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study.Perit Dial Int1996; 16: 352–6.
2.
DaviesS.J., OggC.S., CameronJ.S., PostonS., NobleW.C.Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis.Perit Dial Int1989; 9: 61–4.
3.
LuzarM.A., ColesG.A., FallerB.Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.N Engl J Med1990; 322: 905–9.
4.
SewellC.M., Clarridge-LackeC., WeinmanE.J., YoungE.J.Staphylococcal nasal carriers and subsequent infection in peritoneal dialysis patients.JAMA1982; 248: 1493–5.
5.
HanslikT.M., NewmanL., TessmanM., MorrisseyA.B., FriedlanderM.A.Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications1994; 10: 158–62.
6.
Perez-FontanM., Garcia FalconT., RosalesM.Treatment of S. aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: longterm results.Am JKidney Dis1993; 22: 708–12.
